Integrated Financial Solutions Inc. Purchases New Position in Astera Labs, Inc. $ALAB

Integrated Financial Solutions Inc. purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 11,225 shares of the company’s stock, valued at approximately $2,198,000. Astera Labs makes up about 1.8% of Integrated Financial Solutions Inc.’s portfolio, making the stock its 11th biggest holding.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Sumitomo Mitsui Trust Group Inc. raised its stake in Astera Labs by 21.6% during the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock valued at $1,336,000 after purchasing an additional 2,624 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in Astera Labs by 94.6% during the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock valued at $9,908,000 after acquiring an additional 53,276 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Astera Labs by 34.5% in the second quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock worth $47,208,000 after acquiring an additional 133,961 shares during the last quarter. Corient Private Wealth LLC bought a new stake in shares of Astera Labs in the 2nd quarter worth approximately $543,000. Finally, Paragon Advisors LLC acquired a new position in shares of Astera Labs in the 3rd quarter valued at $1,829,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. JPMorgan Chase & Co. raised their price objective on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. BNP Paribas Exane assumed coverage on Astera Labs in a report on Thursday, November 20th. They set an “outperform” rating on the stock. Needham & Company LLC increased their price target on Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, Weiss Ratings downgraded shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday. Fourteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $192.89.

Insider Buying and Selling

In other news, CFO Michael Truett Tate sold 12,001 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the completion of the transaction, the chief financial officer owned 192,083 shares of the company’s stock, valued at $23,781,796.23. The trade was a 5.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jitendra Mohan sold 94,971 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the sale, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at $179,863,615.59. The trade was a 6.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 389,792 shares of company stock worth $56,013,809 over the last three months. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Price Performance

Shares of ALAB stock opened at $118.83 on Friday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The firm has a 50-day moving average of $158.18 and a 200-day moving average of $172.60. The company has a market cap of $20.23 billion, a P/E ratio of 97.40, a P/E/G ratio of 2.45 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same period in the prior year, the business earned $0.37 earnings per share. Astera Labs’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.